Science Explorer Interactive view Map

ProThera Biologics (United States)

Research works
37
▼ 76% vs 2013–17
Citations
1.1k
30.8 per fractional work
Top-10% rate
60.1%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: ProThera Biologics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at ProThera Biologics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Preterm Infants, Neurodevelopmental Outcomes, Immunotherapy, Gene Therapy, Tumor Targeting and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation9▲ 10.0×19 topics
  2. Epidemiology4▲ 2.7×11 topics
  3. Cancer4▲ 7.0×11 topics
  4. Preterm Infants3▲ 55×3 topics
  5. Immunotherapy3▲ 11×4 topics
  6. Neurodevelopmental Outcomes3▲ 37×4 topics
  7. Gene Therapy2▲ 26×2 topics
  8. Tumor Targeting2▲ 52×2 topics
  9. Antifungal Therapy2▲ 63×3 topics
  10. Arginine Deprivation2▲ 145×1 topic
  11. Bacterial Therapy2▲ 145×1 topic
  12. Glycosylation2▲ 25×2 topics
  13. Hypoxic-Ischemic Encephalopathy2▲ 148×1 topic
  14. Neonatal Encephalopathy2▲ 148×1 topic
  15. Angiogenesis2▲ 13×6 topics
  16. Biomarkers2▲ 8.5×6 topics
  17. Candidiasis2▲ 104×1 topic
  18. Immunity2▲ 14×3 topics
  19. Invasive Fungal Infections2▲ 130×1 topic
  20. Innate Immunity2▲ 13×4 topics
  21. Monoclonal Antibodies2▲ 33×2 topics
  22. Therapeutic Antibodies2▲ 36×2 topics
  23. Metabolism2▲ 6.6×3 topics
  24. Toll-like Receptors2▲ 26×3 topics
  25. Innate Antiviral Responses1▲ 57×1 topic
  26. Management1▲ 4.9×3 topics
  27. Pattern Recognition Receptors1▲ 27×1 topic
  28. PET Imaging1▲ 16×3 topics
  29. Antibody Engineering1▲ 33×1 topic
  30. Autoimmunity1▲ 16×3 topics
  31. Fc Receptors1▲ 33×1 topic
  32. Neurodegeneration1▲ 10×2 topics
  33. Tumor Microenvironment1▲ 9.4×4 topics
  34. Activation1▲ 89×1 topic
  35. Critical Care1▲ 14×3 topics
  36. Extracellular Matrix1▲ 13×4 topics
  37. Infection1▲ 10×2 topics
  38. Macrophage1▲ 55×1 topic
  39. Neuroinflammation1▲ 11×3 topics
  40. Enzymes1▲ 71×2 topics

Which research topics does ProThera Biologics (United States) publish most on?

By volume in 2022–2025: Neonatal and fetal brain pathology, Ecology and Vegetation Dynamics Studies, Neonatal Respiratory Health Research and Plant Taxonomy and Phylogenetics.

  1. 1 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
  2. 2 Ecology and Vegetation Dynamics Studies Nature and Landscape Conservation 0 works
  3. 3 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
  4. 4 Plant Taxonomy and Phylogenetics Ecology, Evolution, Behavior and Systematics 0 works
  5. 5 Plant and animal studies Ecology, Evolution, Behavior and Systematics 0 works
  6. 6 Geography and Environmental Studies Water Science and Technology 0 works
  7. 7 Biochemical and Structural Characterization Molecular Biology 0 works
  8. 8 Botany, Ecology, and Taxonomy Studies Plant Science 0 works
  9. 9 Neuroscience of respiration and sleep Endocrine and Autonomic Systems 0 works
  10. 10 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.0%not open67.0%

World: 28% of research is openly available.

with international co-authors17.9%domestic only82.1%

World: 19% is written across borders.

How has ProThera Biologics (United States)'s research output changed?

Output in 2018–2022 was 76% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in East Providence

All research institutions in East Providence

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.